$11.6M NIH Grant To Study Novel Mechanisms Of Heart Failure Received By Jefferson Scientists at Jefferson Medical College have received a five-year, $11.6 million grant from the National Heart, Lung and Blood Institute to study molecular mechanisms of cardiac injury that lead to heart failure and potential repair processes that occur in the adult failing heart. This project aims to find data that can be translated into novel therapeutic strategies to improve the failing heart.
Source: www.medicalnewstoday.comDelcath Updates Phase III Patient Enrollment As Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited Delcath Systems, Inc. (Nasdaq: DCTH) announced that Richard Taney, President and Chief Executive Officer, provided an update on enrollment numbers in the Company's pivotal Phase III clinical trial today at a gathering of financial and
healthcare industry leaders attending the Rodman & Renshaw 5th Annual Global
Healthcare Conference. Mr.
Source: www.medicalnewstoday.comAbbott Presents Long-term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA� (adalimumab) Maintained Remission Results from an open-label extension study of two Abbott pivotal studies, CHARM and GAIN, demonstrate that adult moderate-to-severe Crohn's patients treated with HUMIRA� (adalimumab) achieved long-term clinical remission and clinical response, respectively, according to data presentations at Digestive Disease Week� (DDW) in San Diego.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 5:00 AM
